MTG-015

MTG-015: Translational Oncology: Discovery and Evalution of Biomarkers/Pharmcogenomics for the Diagnosis and Personalized Management of the Cancer Patient

Additional Information

Purpose

The purpose of this study is to improve the treatment outcome of the cancer patient by studying cancer tissue specimens in order to improve the effectiveness of existing chemotherapy drugs and assist in new drug development.

Principal Investigator(s)
Alan Mullins, MD
Contact
Shawn Sams, RN,BSN,CCR at 270-688-3691
or shawn.sams@owensborohealth.org